AutoDraw
Female Hormone Imbalance Test
This single-day test gives a simple snapshot of your key female hormones along with thyroid function.
£89
29 mins read
The Free Androgen Index (FAI) estimates how much of the testosterone in your blood is biologically active. It is a simple calculation made from two blood results, total testosterone and Sex Hormone Binding Globulin (SHBG), and it is used to check for abnormal androgen levels and to help diagnose conditions such as Polyedocrine Metabolic Ovarian Syndrome (PMOS) in women. Using Forth customer test results collected between January 2021 and July 2026 in the UK, this page explains what your FAI result means, what the normal range looks like for women and men, what causes a high or low result, and how to get tested.
Written by Dr Thom Phillips
September 23, 2026
| What it is | A calculated ratio, not a hormone. Nothing measures FAI directly. |
| How it is worked out | (Total testosterone ÷ SHBG) × 100 |
| Units | None. FAI is a ratio, so the units cancel out. |
| Normal range, women | 0.3 to 5.62 before menopause, 0.19 to 3.63 after |
| Normal range, men | 24 to 104, though FAI is of limited value in men |
| A high result suggests | Androgen excess, most often PMOS in women |
| A low result suggests | Low available testosterone, often the combined pill in women |
| How to test | One blood sample, no fasting needed, morning collection preferred |
The free androgen index measures how much biologically active, or free, testosterone is circulating in the blood. It is not a hormone in its own right and it is not measured directly. It is worked out from two hormones that are measured: total testosterone and Sex Hormone Binding Globulin (SHBG).
Testosterone travels around the body in two states. Most of it is bound to proteins and cannot do anything. A small fraction is unbound and free to act on tissues such as skin, hair follicles, muscle and the ovaries. Total testosterone counts both states together, which is why two people with an identical total testosterone result can have very different symptoms. FAI is the number that separates them.
FAI is most useful in women, where it can pick up androgen excess that a total testosterone result on its own would miss.
Note: if you take high dose biotin therapy (more than 5mg a day), collect your FAI sample at least 8 hours after your last dose, as biotin can interfere with the assay.
Androgens are the group of hormones responsible for male characteristics such as facial hair and a deeper voice. The best known androgen is testosterone.
Both sexes make androgens, just in very different quantities. In men they are produced mainly by the testes, in women mainly by the ovaries, and in both sexes the adrenal glands contribute a share. In women, androgens are not simply a male leftover. They support bone strength, muscle mass, mood, energy and sex drive, and they are the raw material the body converts into oestrogen.
Because androgens affect so many visible tissues, the symptoms of an imbalance tend to show up on the skin and hair long before anyone thinks to test for it.
A useful way to picture what androgens govern is the following short list.
SHBG is a protein made by the liver. Its job is to grip sex hormones and carry them through the bloodstream. While testosterone is held by SHBG it is effectively out of action.
This is why SHBG sits at the heart of the calculation. If your SHBG is high, more of your testosterone is locked up and your FAI falls. If your SHBG is low, more testosterone is left free and your FAI rises, even when your total testosterone has not changed at all.
Several everyday things move SHBG, which in turn moves FAI. The main ones are set out below.
Illustration showing why SHBG determines your free androgen index, comparing high SHBG with more testosterone bound and low SHBG with more free testosterone.
These three results are related but they are not interchangeable, and mixing them up is one of the most common reasons people misread their own report.
Put simply, FAI is not the same thing as free testosterone. It is a shorthand for it, and like any shorthand it works well in some situations and less well in others. It performs best in women with a normal SHBG, and it becomes unreliable when SHBG sits at either extreme.
You may also see it written as serum free androgen index. This means exactly the same thing. Serum is simply the part of the blood sample the two underlying hormones are measured in.
The calculation is straightforward. You divide total testosterone by SHBG, then multiply by 100.
FAI = (total testosterone ÷ SHBG) × 100
Both values must be in the same units, which in the UK means nmol/L for each. If your report gives testosterone in ng/dL, it needs converting before the sum will work.
Diagram of the free androgen index formula, total testosterone divided by SHBG multiplied by 100, with a worked example.
Rather than working it out by hand, you can enter your two results below and the calculator will do it for you, then tell you whether the answer sits inside or outside the reference range.
Remember that a calculator gives you a number, not a diagnosis. Any result that sits outside the range, or any result that comes alongside symptoms, is worth discussing with a doctor.
FAI is a ratio. You are dividing one nmol/L figure by another nmol/L figure, and the units cancel each other out. What is left is a plain number with no units at all. Because that number is then multiplied by 100, it is often written with a percent sign, which is why you will see a woman’s range quoted as 0.3 to 5.62.
So if you are looking for a free androgen index normal range in nmol/L, you will not find one, and that is not an oversight. Only the two inputs have units. The index itself does not.
The ranges below are the ones Forth applies when deciding whether a result is reported as low, healthy or high.
| Group | Low | High |
| Women, before menopause | 0.3 | 5.62 |
| Women, after menopause | 0.19 | 3.63 |
| Men, all ages | 24 | 104 |
Reference ranges vary between laboratories, so always read your result against the range printed on your own report rather than one you have found elsewhere.
For women before menopause, Forth reports a healthy free androgen index as 0.3 to 5.62. After menopause the range narrows to 0.19 to 3.63, because androgen production falls with age.
Forth customer data shows how this plays out in practice. Among women, the typical FAI is 2.52 in the 18 to 24 age bracket and falls steadily to 1.08 in women aged 60 and over.
Chart showing average free androgen index by age and sex, with women and men on separate scales.
The same pattern shows up when you group women by menopause status rather than age. Before menopause the typical FAI is 1.71. After menopause it is 1.18, roughly a third lower.
For men, Forth reports a healthy FAI as 24 to 104. Forth customer data shows a typical value of 55.4 in men aged 18 to 24, declining with each decade to 33.1 in men aged 60 and over.
There is an important caveat here that many sources leave out. UK guidance published through the Society for Endocrinology states that FAI is of limited value in men and might be considered only when total testosterone is not diagnostic of hypogonadism, particularly in men with obesity.
The reason is mathematical rather than clinical. The formula quietly assumes that there is far more SHBG binding capacity available than there is testosterone to fill it. That assumption holds reasonably well in women, whose testosterone levels are low. It does not hold in adult men, whose testosterone concentrations are high enough to saturate a meaningful share of the available SHBG. When researchers compared FAI against free testosterone measured by ultrafiltration, agreement was strong in women and much weaker in men.
In practice this means a man should treat FAI as supporting information rather than an answer. If you are investigating symptoms of low testosterone, a morning total testosterone result, repeated and interpreted alongside Luteinising Hormone (LH) and Follicle Stimulating Hormone (FSH), carries far more weight.
Numbers on their own are hard to place, so the table below shows what a handful of values would mean for different people. Use it as a guide to interpretation rather than a substitute for medical advice.
| Your FAI | Who you are | What it suggests |
| 0.15 | Woman before menopause | Below range. Worth investigating alongside symptoms such as low libido, fatigue or low mood. |
| 0.6 | Woman before menopause | Inside the range, at the lower end. Common in women on the combined pill. |
| 2.0 | Woman before menopause | Comfortably inside the range. This is close to the typical Forth result. |
| 5.0 | Woman before menopause | Inside the range but at the top of it. Worth repeating alongside symptoms. |
| 7.0 | Woman before menopause | Above range. Commonly seen in PMOS and warrants a conversation with your GP. |
| 20 | Man | Below range. Suggests further testing of total testosterone, LH and FSH. |
| 50 | Man | Comfortably inside the range, close to the typical Forth result for men. |
| 110 | Man | Above range, though FAI is unreliable in men, so total testosterone should be checked. |
Context matters more than the number itself. Before drawing conclusions, check what else is going on.
Reassuringly, most results are normal. Across all Forth FAI results, 81.7% came back within range. Among women, 86.4% were healthy, 10.4% were high and 3.3% were low.
Bar chart showing the percentage of free androgen index results that are low, healthy and high, split by sex.
A raised free androgen index means more of your testosterone is biologically active than expected. In women this is the pattern behind most cases of clinical androgen excess. In Forth data, 10.4% of women’s results came back above range.
High androgen levels tend to announce themselves through the skin, hair and menstrual cycle. The most common symptoms of high androgen levels in females are listed below.
If you have been wondering why you are getting facial hair, or you have searched for a blood test for hair loss in females, FAI is usually part of the answer. It is worth asking your GP or requesting a hormone panel rather than treating the symptom cosmetically and leaving the cause unexamined. In more pronounced cases, androgen excess can produce secondary male characteristics such as a deepening voice, and this should always be assessed by a doctor.
The most common cause of high androgen levels in women is PMOS. PMOS affects roughly 10% of women and is characterised by overproduction of testosterone by the ovaries.
PMOS is associated with several other conditions, which is part of why identifying it matters.
PMOS is not the only explanation, and the other causes of hyperandrogenism are set out below.
That final point deserves attention, because Forth data shows how strongly body weight feeds into it. Among women, the typical FAI is 1.33 in those with a BMI between 18.5 and 24.9, and 2.74 in those with a BMI of 30 or above. The number roughly doubles.
Chart showing median free androgen index by BMI group in women, rising with increasing BMI.
The mechanism is insulin. Higher insulin levels suppress SHBG production in the liver, which leaves more testosterone unbound and pushes FAI up. It also stimulates the ovaries to produce more testosterone, which is why weight and PMOS so often travel together.
Diagnosis in adults follows the 2023 international evidence-based guideline, which requires at least two of the following three features.
That third point is the part that changed most recently, and it matters for anyone being assessed outside a gynaecology clinic. Until 2023 the only accepted route was a scan. The current guideline accepts AMH as an alternative, because AMH tracks closely with the follicle count an ultrasound would show and can be measured from a blood sample, which makes assessment possible in primary care rather than only where scanning is available. Whichever route is used, other causes of the same features have to be excluded first, which is why thyroid function and prolactin are usually checked alongside.
FAI speaks directly to the first of those three criteria. International guidance recommends calculated free testosterone, FAI or calculated bioavailable testosterone as the way to assess biochemical hyperandrogenism, because total testosterone alone is not sensitive enough.
There is a shortcut worth knowing about. If your FAI is high and your periods are irregular, you already meet two of the three criteria, so neither an ultrasound nor an AMH result is needed to make the diagnosis. Two caveats apply. These rules are for adults: in adolescents both androgen excess and ovulatory dysfunction are required, and neither ultrasound nor AMH should be used. The morphology criterion is also not recommended within 8 years of a first period, since a high follicle count is normal at that stage.
There is no single universal cut-off, and this is where a lot of online material overstates its case. Different laboratories and studies use different thresholds, and a value above 5 is commonly treated as suggestive of biochemical hyperandrogenism. Forth reports a premenopausal FAI above 5.62 as high. Either way, a raised FAI supports a PMOS diagnosis, it does not make one on its own.
A full PMOS workup normally includes several hormones alongside FAI.
High androgen levels can interfere with ovulation, and if you are not ovulating regularly, conceiving becomes harder. This is one of the main routes by which PMOS affects fertility.
The encouraging part is that this is often modifiable. Because insulin resistance and body weight both push FAI upwards, changes that improve insulin sensitivity frequently improve ovulation as well. Fertility difficulties linked to androgen excess are also among the more treatable causes, so an abnormal FAI is a reason to seek advice rather than a reason to assume the worst.
It is uncommon for androgen levels to become genuinely too high in men, and when they do the cause is usually external rather than internal.
The effects depend entirely on the cause. If the adrenal glands are responsible there may be few outward signs, though testicular function and fertility can still be affected. Where anabolic steroid use is the cause, the symptoms are more recognisable.
Bear in mind the caveat from earlier. Because FAI is unreliable at the male end of the SHBG scale, a high FAI in a man should always be checked against a direct total testosterone result before anything is concluded.
A low free androgen index means less testosterone is biologically available than expected. In Forth data, 3.3% of women’s results and 10.8% of men’s results came back below range.
Low androgen levels in women are easy to miss, because the symptoms are diffuse and are often put down to stress, age or poor sleep. The most common androgen deficiency symptoms are set out below.
Age is the most common factor. Androgens decline naturally over time, and some women barely notice while others are very sensitive to the change. Before menopause, women produce around three times as much testosterone as oestrogen, so the fall matters more than people expect.
Medication is the next most common cause, and Forth data shows this clearly:
That is a drop of roughly 60%, and it happens because oral oestrogen raises SHBG.
Progesterone-only methods behave very differently. Women using the progesterone-only pill, Mirena, coil or implant had a typical FAI of 1.85, slightly higher than women using nothing at all. This is the single most useful thing to know before you panic about a low result. If you are on the combined pill, a low FAI may simply be your contraception showing up in your bloodwork.
Chart comparing median free androgen index in women on hormonal contraception versus women not using it, split by contraceptive type.
Beyond age and medication, the other causes of low androgen levels in females are listed below.
A low free androgen index in men can indicate testosterone deficiency. Age associated testosterone deficiency syndrome, also called late onset hypogonadism, is diagnosed when blood testosterone sits below the reference range for young healthy adult men.
Low testosterone is also commonly associated with type 2 diabetes. Some research suggests higher testosterone levels reduce the risk of type 2 diabetes in men, making testosterone a protective factor against metabolic disease.
Common symptoms of late onset hypogonadism are set out below.
In Forth data, 24.5% of men’s FAI results fell outside the reference range, split between 10.8% below and 13.7% above. Given the known limitations of FAI in men, a large share of these will reflect the calculation rather than a genuine hormone problem, which is exactly why total testosterone should always be read alongside it.
The right approach depends entirely on why it is low in the first place.
Where there is no specific medical cause, the general levers are the ones you would expect.
Testosterone therapy for women is a specialist area with limited licensed options in the UK, so it should only be considered under medical supervision.
Because FAI is a ratio, there are two ways to bring it down: reduce testosterone production, or raise SHBG so that more testosterone is bound. In practice, most of what works does both.
The most effective lever is metabolic. Given the BMI pattern in Forth data, improving insulin sensitivity is the intervention with the strongest evidence behind it and the largest effect. That means the following.
Forth data also shows a modest association with exercise in women. Typical FAI was 1.63 among women exercising up to 5 hours a week and 1.30 among those exercising 11 to 15 hours a week. This is a smaller and less consistent effect than the BMI pattern, so treat it as a hint rather than a rule.
Several foods have been suggested to help lower testosterone levels in women, although the scientific evidence supporting them is limited.
Where lifestyle is not enough, medical options exist:
All of these are prescription only and need to be discussed with a doctor, since they carry their own considerations and are not suitable if you are trying to conceive.
Some research has reported a significant benefit of vitamin D supplementation on male hormone concentrations. A study published in 2021 found that vitamin D supplementation lowered hirsutism scores and androgen levels in overweight women with PMOS.
This matters more than it might sound, because deficiency is widespread. Forth data shows that 57% of UK adults are deficient in vitamin D. The NHS recommends that all UK adults consider a daily 10 microgram vitamin D supplement during autumn and winter, because the sun is not strong enough for the body to make it.
Vitamin D is not a treatment for androgen excess on its own. Correcting a deficiency is sensible regardless, and it may help at the margins.
A blood test tells you a number. A doctor tells you what to do about it. Book an appointment if any of the following apply.
Bring your results with you, ideally including total testosterone and SHBG rather than the FAI figure alone, since your GP will want to see the inputs as well as the output.
If you have been searching for how to check androgen levels in females, or which blood test shows androgen levels, this is the section you need.
There is no such thing as a machine that measures FAI. An FAI blood test measures two things and calculates the third.
This is why the FAI cannot be ordered in isolation. Any test that reports FAI will always include the two underlying results, which is useful, because you need all three to interpret any of them properly.
Preparation is simpler than most people assume. The key points are below.
Chart showing median free androgen index by day of the menstrual cycle in women with regular periods.
If you are testing other hormones at the same time, cycle day may still matter a great deal. Progesterone in particular needs to be collected around day 21 of a 28 day cycle, so follow the guidance for the full panel rather than for FAI alone.
Results are usually available within 2 working days of your sample reaching the lab, and you will be notified as soon as they are ready to view. Your report will show your FAI alongside total testosterone and SHBG, each with its reference range, and will flag anything outside that range.
Read the three together rather than separately. A high FAI with a normal testosterone and a low SHBG tells a different story from a high FAI driven by high testosterone, and only the first is really a binding problem rather than a production one.
All of the tests below report the free androgen index. Choose the one that matches what you are trying to find out.
If you only want to check specific markers, you can hand pick them in the bespoke builder. Selecting the free androgen index automatically includes the total testosterone and SHBG it is calculated from, so you will see all three on your report. This is the most economical option if you have tested before and simply want to recheck.
FAI stands for free androgen index. The word index is the important one: it is a calculated ratio rather than a measured hormone level, which is why it has no units and why no laboratory can test for it directly.
A high FAI is not dangerous in itself. It is a signal, not a disease. In women it most often points to PMOS, which is manageable rather than dangerous, though it is worth addressing because of its links to insulin resistance, fertility and long term metabolic health. A markedly high result that has appeared quickly does need prompt medical assessment, as rapid onset androgen excess can occasionally indicate a tumour of the ovary or adrenal gland.
Because your SHBG is probably low. FAI compares the two, so a normal amount of testosterone paired with less binding protein leaves more of it unbound and pushes the index up. This is the most common reason for the combination, and it points towards insulin resistance, weight or thyroid function rather than towards the ovaries producing too much testosterone. Your report will show your SHBG result, so check it before assuming the problem is production.
No. Free testosterone is a measured concentration. FAI is an estimate of the same thing expressed as a ratio. Where precision matters, free testosterone measured by equilibrium dialysis is the more accurate method.
No. A high FAI satisfies one of the three diagnostic criteria, so it supports a diagnosis without making one on its own.
Not directly. Both values have to be in the same units before the sum works, and SHBG is almost always reported in nmol/L. Convert your testosterone first by dividing the ng/dL figure by 28.84, then divide by SHBG and multiply by 100.
There is no fixed schedule. If you are tracking a change, whether that is a new medication, weight loss or a lifestyle programme, allow at least three months between tests, since SHBG responds slowly. If you are investigating a symptom rather than tracking progress, a single result interpreted alongside your symptoms is usually enough to decide the next step with a doctor.
FAI is nearly always reported with total testosterone and SHBG, since it is calculated from them. Depending on why you are testing, it may also sit alongside LH, FSH, AMH, oestradiol, progesterone, prolactin and TSH.
Serum free androgen index means the same as free androgen index. Serum is the liquid part of the blood that remains once cells and clotting factors are removed, and it is the fraction the two underlying hormones are measured in. The word describes the sample, not the test.
All these tests include Free Androgen Index. Select the test that suits your personal needs.
Certified for quality & security
‘International evidence-based guideline for the assessment and management of polycystic ovary syndrome – 2023’ (2023) REPRODUCTIVE ENDOCRINOLOGY, (69), pp. 59–79. doi:10.18370/2309-4117.2023.69.59-79.
Mazer N. A. (2002). Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments. International journal of fertility and women's medicine, 47(2), 77–86.
Jakiel, G., & Baran, A. (2005). Hipoandrogenizm u kobiet [Androgen deficiency in women]. Endokrynologia Polska, 56(6), 1016–1020.
Yao, Q. et al. (2018) ‘Testosterone level and risk of type 2 diabetes in men: A systematic review and meta-analysis’, Endocrine Connections, 7(1), pp. 220–231. doi:10.1530/ec-17-0253.
Mínguez-Alarcón, L. et al. (2017) ‘Fatty acid intake in relation to reproductive hormones and testicular volume among Young Healthy Men’, Asian Journal of Andrology, 19(2), p. 184. doi:10.4103/1008-682x.190323.
Thom works in NHS general practice and has a decade of experience working in both male and female elite sport. He has a background in exercise physiology and has published research into fatigue biomarkers.
Dr Thom Phillips
Chief Medical Officer